ATYR
aTyr Pharma, Inc.
0.29$
+1.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -59.0% | +89.2% | -50.3% | +1.3% | -100.3% | – | +1.0% | +0.5% | +1.3% | +0.0% | +2.8% | – | |
| – | -0.8% | +12.3% | -1.8% | +3.4% | +2.4% | +53.0% | +10.8% | +0.2% | -7.7% | +8.3% | -12.4% | – | |
| – | +219.0% | -315.7% | – | – | -54.6% | -197.3% | – | -7.2% | -86.8% | -687.2% | – | – | |
| – | -96.9% | +0.0% | -52.9% | +87.5% | +66.7% | -100.0% | – | +311.1% | -16.2% | +345.2% | -47.1% | – | |
| – | +306.5% | -107.6% | – | +166.7% | -133.9% | -27.4% | – | -717.3% | – | -30.1% | +33.3% | – | |
| – | – | – | – | – | – | – | – | -49.4% | – | – | – | – | |
| – | – | – | – | – | +2.4% | +2.3% | +1.5% | +2.3% | +2.2% | +2.2% | +2.1% | – | |
| – | +125.0% | +28.1% | +73.4% | -100.8% | – | -1.1% | -3.9% | +65.5% | -100.4% | +8.4% | -9.2% | – | |
| – | – | -223.4% | – | – | -108.1% | – | – | -253.8% | – | -128.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.